Sage Therapeutics Inc. buy BiotechBee
Start price
24.06.23
/
60%
€44.20
Target price
31.12.25
€60.00
Performance (%)
-78.35%
Price
24.07.24
€9.57
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Sage Therapeutics Inc. is performing very badly with a performance of -78.35%. This prediction currently runs until 31.12.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Sage Therapeutics Inc. | -15.365% | -15.365% | -70.829% |
iShares Core DAX® | 1.280% | 1.320% | 13.605% |
iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% |
iShares Nikkei 225® | -2.006% | -1.389% | 8.973% |
iShares S&P 500 | -0.662% | -1.884% | 23.684% |
According to BiotechBee what are the pros and cons of Sage Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Buy mit Kursziel 60,0